Drug
Information |
Name | SIPATRIGINE |
Synonyms | SIPATRIGINE |
Structure |
Click to save drug structure in 3D MOL format
Click to save drug structure in 2D MOL format |
Target | Sodium channel protein type I alpha subunit |  | Inhibitor | [1] |
Sodium channel protein type III alpha subunit |  | Inhibitor | [1] |
Sodium channel protein type IV alpha subunit |  | Inhibitor | [2] |
Sodium channel protein type IX alpha subunit |  | Inhibitor | [2] |
Sodium channel protein type V alpha subunit |  | Inhibitor | [3] |
Sodium channel protein type VI alpha subunit |  | Inhibitor | [3] |
Sodium channel protein type X alpha subunit |  | Inhibitor | [2] |
Voltage-gated L-type calcium channel alpha-1D subunit |  | Inhibitor | [4] |
Ref 1 | J Med Chem. 2002 Aug 15;45(17):3755-64.Synthesis and structure-activity relationships of 6,7-benzomorphan derivatives as use-dependent sodium channel blockers for the treatment of stroke. To Reference |
Ref 2 | J Med Chem. 2009 May 14;52(9):2694-707.Oxadiazolylindazole sodium channel modulators are neuroprotective toward hippocampal neurones. To Reference |
Ref 3 | J Med Chem. 2001 Jan 18;44(2):115-37.Medicinal chemistry of neuronal voltage-gated sodium channel blockers. To Reference |
Ref 4 | Bioorg. Med. Chem. Lett. 5(19):2259-2262 (1995) To Reference |